Literature DB >> 26935642

MiR-608 inhibits the migration and invasion of glioma stem cells by targeting macrophage migration inhibitory factor.

Zhenhua Wang1, Yixue Xue2, Ping Wang2, Jiaqi Zhu1, Jun Ma2.   

Abstract

Glioma stem cells (GSCs) contribute to the malignant biological behavior of these tumors and have also been shown to be resistant to radiation and chemotherapy. Recently, a variety of microRNAs (miRNAs) has been found to present altered expression and to play an important oncogenic role or tumor-suppressive function in cancer stem cells (CSCs). microRNA-608 (miR-608) is one of the newly discovered microRNAs, and its biological functions remain unclear. Human macrophage migration inhibitory factor (MIF) is a well known oncogene associated with tumor recurrence and the poor prognosis of gliomas. In the present study, we found that miR-608 negatively regulated the gene expression of MIF at the post‑transcriptional level and plays a tumor-suppressive role by targeting MIF in GSCs. We found that miR-608 expression was significantly downregulated and the expression levels of the MIF gene and protein showed an increase in the GSCs. miR-608 overexpression significantly attenuated the proliferation, migration and invasion, and induced the apoptosis of GSCs. The dual-luciferase reporter system revealed that the 3'UTR of MIF is a direct target of miR-608, and miR-608 negatively regulates the gene expression of MIF at the post-transcriptional level by targeting its 3'UTR. Furthermore, we demonstrated that miR-608 overexpression inhibited the malignant behavior of GSCs by downregulating MIF. Western blot results showed that the inhibition of MIF resulted in the inactivation of the PI3K/AKT and JNK pathways. These results demonstrate that miR-608 acts as a potential tumor suppressor and provide insight into new therapeutic targets for malignant glioma.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26935642     DOI: 10.3892/or.2016.4652

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  19 in total

Review 1.  MicroRNAs in prostate cancer: From function to biomarker discovery.

Authors:  Ahmed A Moustafa; Hogyoung Kim; Rasha S Albeltagy; Ola H El-Habit; Asim B Abdel-Mageed
Journal:  Exp Biol Med (Maywood)       Date:  2018-06

2.  Suppression of long noncoding RNA MALAT1 inhibits the development of uveal melanoma via microRNA-608-mediated inhibition of HOXC4.

Authors:  Shuai Wu; Han Chen; Ling Zuo; Hai Jiang; Hongtao Yan
Journal:  Am J Physiol Cell Physiol       Date:  2020-01-08       Impact factor: 4.249

3.  Suppression of MIF-induced neuronal apoptosis may underlie the therapeutic effects of effective components of Fufang Danshen in the treatment of Alzheimer's disease.

Authors:  Cheng-Jie Liang; Jia-Huang Li; Zhen Zhang; Ju-Yan Zhang; Shu-Qun Liu; Jie Yang
Journal:  Acta Pharmacol Sin       Date:  2018-05-17       Impact factor: 6.150

4.  HOXD-AS1 promotes cell proliferation, migration and invasion through miR-608/FZD4 axis in ovarian cancer.

Authors:  Yanyan Wang; Wenjuan Zhang; Yuyan Wang; Shanfeng Wang
Journal:  Am J Cancer Res       Date:  2018-01-01       Impact factor: 6.166

Review 5.  Aberrant miRNAs Regulate the Biological Hallmarks of Glioblastoma.

Authors:  Wanli Yu; Sai Liang; Chunzhi Zhang
Journal:  Neuromolecular Med       Date:  2018-09-04       Impact factor: 3.843

6.  IGF2 mRNA binding protein 3 (IMP3) promotes glioma cell migration by enhancing the translation of RELA/p65.

Authors:  Shruti Bhargava; Abhirami Visvanathan; Vikas Patil; Anuj Kumar; Santosh Kesari; Saumitra Das; Alangar S Hegde; Arimappamagan Arivazhagan; Vani Santosh; Kumaravel Somasundaram
Journal:  Oncotarget       Date:  2017-06-20

7.  MicroRNA-608 inhibits proliferation of bladder cancer via AKT/FOXO3a signaling pathway.

Authors:  Zhen Liang; Xiao Wang; Xin Xu; Bo Xie; Alin Ji; Shuai Meng; Shiqi Li; Yi Zhu; Jian Wu; Zhenghui Hu; Yiwei Lin; Xiangyi Zheng; Liping Xie; Ben Liu
Journal:  Mol Cancer       Date:  2017-05-26       Impact factor: 27.401

Review 8.  Pathogenic role for macrophage migration inhibitory factor in glioblastoma and its targeting with specific inhibitors as novel tailored therapeutic approach.

Authors:  Katia Mangano; Emanuela Mazzon; Maria Sofia Basile; Roberto Di Marco; Placido Bramanti; Santa Mammana; Maria Cristina Petralia; Paolo Fagone; Ferdinando Nicoletti
Journal:  Oncotarget       Date:  2018-04-03

9.  CDC42 expression is altered by dioxin exposure and mediated by multilevel regulations via AhR in human neuroblastoma cells.

Authors:  Tuan Xu; Heidi Q Xie; Yunping Li; Yingjie Xia; Yangsheng Chen; Li Xu; Lingyun Wang; Bin Zhao
Journal:  Sci Rep       Date:  2017-08-31       Impact factor: 4.379

10.  No Association Between MicroRNA-608 rs4919510 G>C Polymorphism and Digestive System Cancers Susceptibility: A Meta-Analysis Based on 10,836 Individuals.

Authors:  Xue-Feng Li; Ju-Kun Song; Jun-Wei Cai; Yu-Qin Zeng; Min Li; Jie Zhu; Yu-Ming Niu
Journal:  Front Physiol       Date:  2018-06-07       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.